Table 1. Clinical and demographic characteristics of patients.
Values are the median and range.
| Enrolment | Treated | Per Protocol | |
|---|---|---|---|
| n = 28 | n = 21 | n = 19 | |
| Age (years) | 63.5 (47–73) | 61 (47–71) | 60 (47–71) |
| Sex (male in %) | 64.29 | 71.43 | 68.42 |
| Body size (m) | 1.75 (1.59–1.91) | 1.78 (1.61–1.91) | 1.77 (1.61–1.91) |
| Body weight (kg) | 81.5 (56.5–105) | 86 (56.5–103) | 86 (56.5–103) |
| FVC (%) | 76 (35–99) | 77 (39–99) | 78 (39–99) |
| FEV1 (%) | 52.5 (24–82) | 53 (26–82) | 56 (26–82) |
| FEV1 (%) After Salbutamol 400 μg | 56.5 (26–82) | 59 (32–82) | 61 (37–82) |
| Pack years (n) | 45 (15–100) | 47 (15–100) | 47 (15–100) |
| Active smokers (%) | 64.29 | 61.91 | 63.16 |
| CAT (points) | 22.5 (8–33) | 22 (10–32) | 22 (10–32) |